All members have the option of attending our various HTC-centric events which include:
Date: Thursday, March 20th, 2025 Time: 2:00pm - 3:00pm ET TITLE: Takeda FVIII Portfolio OBJECTIVE: Please join Takeda leadership to review Takeda FVIII Products & Resources Available. INTENDED AUDIENCE: All HTC staff SPEAKER: Anthea Cherednichenko, VP US Hematology Franchise Head Anthea leads the sales and marketing teams for Takeda’s Hematology portfolio. Anthea Read the full article...
Date: Thursday, April 3rd, 2025 Time: 2:00pm - 3:00pm ET WEBINAR TOPIC: Alhemo (concizumab-mtci): A new option for patients living with hemophilia A or B with inhibitors OBJECTIVE: To provide a prescribing information overview of the recently FDA approved medication, Alhemo (concizumab-mtci), for patients living with hemophilia A or B with Read the full article...
Date: April 17th, 2025 Click here for info.
Date: April 23rd - 25th Location: Dubai
Date: April 27 - 29, 2025 Location: Orlando, FL Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
Date: April 29 - May 1, 2025 Location: Orlando, FL Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
Date: Tuesday, May 6th, 2025 Time: 2:00pm - 3:00pm ET WEBINAR TOPIC: Complications and challenges associated with hemophilia and a rebalancing approach with HYMPAVZI™ (marstacimab-hncq) OBJECTIVES: Educate attendees on complications and challenges associated with hemophilia, the novel mechanism of action of HYMPAVZI, the BASIS Ph3 clinical trial results and dosage and Read the full article...
Date: Wednesday, May 7th, 2025 Time: 1:00pm - 2:00pm ET WEBINAR TOPIC: Exploring data and expert perspectives on Qfitlia™ (fitusiran) OBJECTIVE: During this program, we will explore data and expert perspectives on Qfitlia™ (fitusiran), a newly approved prophylactic treatment for patients with hemophilia A and B, with or without inhibitors. SPEAKER: Vanessa Read the full article...
Date: Tuesday, May 13th, 2025 Time: 1:00pm - 2:00pm ET WEBINAR TOPIC: A Collaborative Journey - ROCTAVIAN Patient & Provider Perspectives OBJECTIVE: Join us for an insightful webinar exploring the real-world experiences of patients and providers with ROCTAVIAN. Hear firsthand accounts of the treatment journey, from initial consultations and administration to outcomes Read the full article...
Date: May 14 - 16, 2025 Location: Phoenix, AZ Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
Date: May 19th - 21st Location: Indianapolis, IN
Date: June 21st - 25th Location: Washington, DC
Date: Thursday, June 26th, 2025 Time: 1:00pm - 2:00pm ET WEBINAR TITLE: Washington Update SESSION OBJECTIVE: Come to hear the latest on actions in Washington that could impact your HTC and your patients – from 340B reform and federal funding for hemophilia programs, to Congress’ “One Big Beautiful Bill” and how it could Read the full article...
Date: July 16th - 17th Location: Indianapolis, IN
Date: Tuesday, July 22nd, 2025 Time: 1:00pm - 2:00pm ET WEBINAR TOPIC: Review the clinical benefits of wilate®, highlighting the benefits vs current vWD therapies. OBJECTIVES: Understand the attributes of wilate® for vWD: 1:1 ratio which mimics the physiologic activity of vWF and FVIII and the synchronous decay curves, which facilitates Read the full article...
Date: Tuesday, August 12th, 2025 Time: 1:00pm - 2:00pm ET WEBINAR TITLE: Big Bill, Big Insurance Impact - What do HTCs need to know now about coming health insurance changes and how to prepare? SESSION OBJECTIVE: The One Big Beautiful Bill Act and other Washington policies are reshaping the insurance landscape for HTCs Read the full article...
Date: August 21st - 23rd Location: Denver, CO
Date: Wednesday, August 27th, 2025 Time: 2:00pm - 3:00pm ET WEBINAR TITLE: Juggling Fall Routines Can Be Complicated. Help your patients keep their hemophilia treatment simple with subcutaneous HYMPAVZI (marstacimab-hncq): Learn More From a Real-World Patient Experience. OBJECTIVES: To educate attendees on challenges, shared decision making in hemophilia and introduce Read the full article...
Date: Thursday, September 4th, 2025 Time: 1:00pm - 2:00pm ET WEBINAR TITLE: Advancing Care with ROCTAVIAN® (valoctocogene roxaparvovec-rvox): Clinical Evidence, Patient Perspective & Contract Opportunities. OBJECTIVES: Explore updates to HEM Alliance member contract terms and the associated provider economics. Review the latest clinical data updates, describing the long-term efficacy and safety of Read the full article...
Date: Wednesday, September 10th, 2025 Time: 1:00pm - 2:00pm ET WEBINAR TITLE: Mental Health and Substance Use in the Bleeding Disorders Community. DESCRIPTION: The bleeding disorders community does not have the same access to inpatient and residential mental health and substance use treatment that the general population does. This webinar will Read the full article...
